Merck to ship Dulera inhaler for asthma
Merck next month plans to release Dulera Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older.
CDR
Chain Drug Consortium, NCPA unveil new partnership
The Chain Drug Consortium (CDC) and National Community Pharmacists Association (NCPA) are stepping up their collaboration to better leverage the strengths of each organization to more effectively advance the interests of community pharmacists and their patients.
Connecticut, CVS Caremark at odds over Rx discount program
Connecticut’s attorney general has begun an investigation of CVS Caremark Corp. over a disagreement about extending a consumer discount drug program offered by the company to the state’s Medicaid program.
Martindale named Rite Aid’s COO
With John Standley taking the reins as chief executive officer, Rite Aid Corp. has promoted Ken Martindale to chief operating officer. Martindale assumes the new post immediately, Rite Aid said Thursday.
Wasson: Walgreens’ core strategies are on target
In spite of a disappointing third quarter, Walgreen Co. chief executive officer Greg Wasson said the company remains on track with its core strategies — notably its Customer-Centric Retailing (CCR) store optimization initiative.
Canadian pharmacies join new e-prescription network
More than a dozen pharmacy banners are participating in the Ontario and Quebec launch of ZoomMed Inc.’s e-Pic Communication Network, which along with the company’s ZRx Prescriber application lets doctors send electronic prescriptions from smart wireless devices.
Cephalon, APhA, ACPA team up to stop Rx abuse
Cephalon Inc. has partnered with the American Pharmacists Association (APhA) and the American Chronic Pain Association (ACPA) to broaden the biopharmaceutical company’s "When Good Medicines Become Bad Drugs" program.
AXE enlists JAGTAG for mobile marketing push
Unilever’s AXE men’s grooming brand is using mobile 2D barcode technology from JAGTAG to help drive a marketing campaign for the launch of its new AXE Twist products. According to Princeton, N.J.
Maker of Stopain extends Arthritis Foundation sponsorship
DRJ Group Inc., the maker of Stopain all-natural topical analgesics, is continuing its support of the Arthritis Foundation by renewing its proceeds sponsorship.
Standley takes helm as new Rite Aid CEO
Before the end of the day, Rite Aid Corp. will get a new chief executive officer: John Standley. Standley, 47, is set to become Rite Aid president and CEO after the company’s annual shareholder meeting Wednesday in Camp Hill, Pa. He will take the chief executive reins from Mary Sammons, 63,
Rite Aid posts smaller loss in 1Q
Rite Aid Corp. saw sales dip in its fiscal 2011 first quarter but recorded a smaller year-over-year loss and topped Wall Street’s earnings forecast. The drug store chain on Wednesday said its net loss for the 13-week first quarter ended May 29 was $73.7 million, or 9 cents per diluted share,
Hallmark unveils ‘Girlfriends’ card collection
Hallmark Cards has launched the Girlfriends collection, a line of greeting cards and gifts designed to help women connect in a fun, humorous and meaningful way.
Takeda ships ACTOplus met XR tablets for diabetes
Takeda Pharmaceuticals North America Inc. said ACTOplus met XR tablets, an extended-release version of the diabetes combination medication ACTOplus met (pioglitazone HCl and metformin HCl), are now available in U.S. pharmacies.
Valeant, Biovail plan to merge
Specialty pharmaceutical makers Valeant and Biovail have agreed to merge, with the combined company to be called Valeant Pharmaceuticals International Inc.
GPhA names interim executive team
The Generic Pharmaceutical Association (GPhA) has formed an interim executive team to lead the organization until it appoints a new chief executive officer to replace Kathleen Jaeger, who is due to step down from the post later this month.
Walmart, Lilly partner to provide ‘affordable’ insulin
Walmart and drug maker Eli Lilly & Co. are teaming up to provide what they call an "affordable insulin option" for people with diabetes.